argenx SE
XBRU:ARGX

Watchlist Manager
argenx SE Logo
argenx SE
XBRU:ARGX
Watchlist
Price: 577.6 EUR 2.27% Market Closed
Market Cap: 34.5B EUR
Have any thoughts about
argenx SE?
Write Note

Wall Street
Price Targets

ARGX Price Targets Summary
argenx SE

Wall Street analysts forecast ARGX stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARGX is 573.91 EUR with a low forecast of 156.55 EUR and a high forecast of 714 EUR.

Lowest
Price Target
156.55 EUR
73% Downside
Average
Price Target
573.91 EUR
1% Downside
Highest
Price Target
714 EUR
24% Upside
argenx SE Competitors:
Price Targets
CDMO
Avid Bioservices Inc
6% Upside
IMTX
Immatics NV
140% Upside
4891
TMS Co Ltd
278% Upside
IMRX
Immuneering Corp
445% Upside
BNTX
BioNTech SE
24% Upside
OXB
Oxford BioMedica PLC
25% Upside
RPHM
Reneo Pharmaceuticals Inc
1 880% Upside
2616
CStone Pharmaceuticals
31% Upside

Revenue
Forecast

Revenue Estimate
argenx SE

For the last 8 years the compound annual growth rate for argenx SE's revenue is 91%. The projected CAGR for the next 3 years is 47%.

91%
Past Growth
47%
Estimated Growth
Estimates Accuracy
-25%
Average Miss

Operating Income
Forecast

Operating Income Estimate
argenx SE

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
argenx SE

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-26%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ARGX's stock price target?
Price Target
573.91 EUR

According to Wall Street analysts, the average 1-year price target for ARGX is 573.91 EUR with a low forecast of 156.55 EUR and a high forecast of 714 EUR.

What is argenx SE's Revenue forecast?
Projected CAGR
47%

For the last 8 years the compound annual growth rate for argenx SE's revenue is 91%. The projected CAGR for the next 3 years is 47%.

Back to Top